Document Format Files
Seq | Description | Document | Type | Size |
---|---|---|---|---|
1 | FORM 10-K | alxn10k12312017.htm | 10-K | 3244932 |
2 | EMPLOYMENT AGREEMENT | alxnex10612312017.htm | EX-10.6 | 108077 |
3 | FORM OF 2017 INCENTIVE PLAN RESTRICTED STOCK UNIT AGREEMENT | alxnex103212312017.htm | EX-10.32 | 43778 |
4 | FORM OF 2017 INCENTIVE PLAN NONQUALIFIED STOCK OPTION AGREEMENT | alxnex103312312017.htm | EX-10.33 | 43588 |
5 | FORM OF 2017 INCENTIVE PLAN PERFORMANCE STOCK UNIT AGREEMENT (TSR) | alxnex103412312017.htm | EX-10.34 | 33945 |
6 | FORM OF 2017 INCENTIVE PLAN PERFORMANCE STOCK UNIT AGREEMENT (R&D UNITS) | alxnex103512312017.htm | EX-10.35 | 58769 |
7 | 2017 INCENTIVE PLAN RULES FOR AWARDS GRANTED TO PARTICIPANTS IN FRANCE | alxnex103612312017.htm | EX-10.36 | 56482 |
8 | FORM OF 2017 INCENTIVE PLAN RESTRICTED STOCK UNIT AGREEMENT FOR FRENCH PARTICIPA | alxnex103712312017.htm | EX-10.37 | 68549 |
9 | FORM OF 2017 INCENTIVE PLAN GLOBAL STOCK OPTION AGREEMENT | alxnex103812312017.htm | EX-10.38 | 80856 |
10 | FORM OF 2017 INCENTIVE PLAN RESTRICTED STOCK UNIT AGREEMENT FOR NON-US PARTICIPA | alxnex103912312017.htm | EX-10.39 | 167521 |
11 | SUBSIDIARIES OF ALEXION PHARMACEUTICALS, INC. | alxnex21112312017.htm | EX-21.1 | 13511 |
12 | CONSENT OF PRICEWATERHOUSECOOPERS LLP | alxnex23112312017.htm | EX-23.1 | 3019 |
13 | CERTIFICATION OF CEO PURSUANT TO SECTION 302 | alxnex31112312017.htm | EX-31.1 | 13442 |
14 | CERTIFICATION OF CFO PURSUANT TO SECTION 302 | alxnex31212312017.htm | EX-31.2 | 13600 |
15 | CERTIFICATION OF CEO PURSUANT TO SECTION 906 | alxnex32112312017.htm | EX-32.1 | 7187 |
16 | CERTIFICATION OF CFO PURSUANT TO SECTION 906 | alxnex32212312017.htm | EX-32.2 | 7089 |
23 | accumclinicalspend17.jpg | GRAPHIC | 27422 | |
24 | acquisitioncosts17.jpg | GRAPHIC | 11350 | |
25 | alawalxn.jpg | GRAPHIC | 41252 | |
26 | alexionlogoa08.jpg | GRAPHIC | 15115 | |
27 | briangoffalxn.jpg | GRAPHIC | 43993 | |
28 | consnetproductsales17.jpg | GRAPHIC | 29695 | |
29 | contingentconsideration17.jpg | GRAPHIC | 11484 | |
30 | cos17.jpg | GRAPHIC | 14108 | |
31 | incometaxes17.jpg | GRAPHIC | 20583 | |
32 | indranifranchinialxn.jpg | GRAPHIC | 44551 | |
33 | intangibleimpairment17.jpg | GRAPHIC | 8637 | |
34 | jmoriartyalxn.jpg | GRAPHIC | 41655 | |
35 | johnorloffalxn.jpg | GRAPHIC | 40897 | |
36 | julieoneillalxn.jpg | GRAPHIC | 30381 | |
37 | kanuma-logo.jpg | GRAPHIC | 14690 | |
38 | kanumanetproductsales17.jpg | GRAPHIC | 16836 | |
39 | ludwighanstonalxn.jpg | GRAPHIC | 31211 | |
40 | otherincomeexp17.jpg | GRAPHIC | 25066 | |
41 | pclancyalxn.jpg | GRAPHIC | 36119 | |
42 | purchasedintangibleamort17.jpg | GRAPHIC | 12803 | |
43 | pvfx16.jpg | GRAPHIC | 11263 | |
44 | pvfx17.jpg | GRAPHIC | 11560 | |
45 | rdclinical17.jpg | GRAPHIC | 53009 | |
46 | rdcosts17.jpg | GRAPHIC | 35602 | |
47 | restructuringexpenses17.jpg | GRAPHIC | 11229 | |
48 | sgacosts17.jpg | GRAPHIC | 22740 | |
49 | soliris-logo.jpg | GRAPHIC | 13770 | |
50 | solirisnetproductsales17.jpg | GRAPHIC | 29193 | |
51 | strensiq-logo.jpg | GRAPHIC | 12778 | |
52 | strensiqnetproductsales17.jpg | GRAPHIC | 19298 | |
53 | totalreturngraph2017.jpg | GRAPHIC | 60637 | |
54 | wagnerhalxn.jpg | GRAPHIC | 26975 | |
Complete submission text file | 0000899866-18-000022.txt | 18861008 |
Data Files
Seq | Description | Document | Type | Size |
---|---|---|---|---|
17 | XBRL INSTANCE DOCUMENT | alxn-20171231.xml | EX-101.INS | 4110643 |
18 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | alxn-20171231.xsd | EX-101.SCH | 94212 |
19 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | alxn-20171231_cal.xml | EX-101.CAL | 165501 |
20 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | alxn-20171231_def.xml | EX-101.DEF | 715990 |
21 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | alxn-20171231_lab.xml | EX-101.LAB | 1397060 |
22 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | alxn-20171231_pre.xml | EX-101.PRE | 929772 |
IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27756 | Film No.: 18586098
SIC: 2834 Pharmaceutical Preparations